Atlas Trials

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

Clinical trial NCT00171730 · COMPLETED

Trial details

NCT number
NCT00171730
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acromegaly
Start date
2004-08-24
Primary completion
2013-12-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.